# Sophont

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sophont

- Industry: Healthcare IT
- Headquarters: Dover, US
- Website: www.sophontai.com/
- Total disclosed funding: $9.2M
- Latest round: Seed (Sep 11, 2025)
- Investors on record: 6

## About

Based in California, Sophont Inc. provides AI-driven technological solutions to enhance operational efficiency and productivity across various sectors.Sophont Inc. specializes in AI technology aimed at improving business productivity. Founded in 2025 in Dover, US, the company has undertaken two deals thus far. The founder's history is not specified, and there are no available details regarding previous companies founded. The company has not undergone any significant strategic pivots or changes in operations since its founding.Sophont Inc. specializes in providing advanced technological solutions that enhance efficiency and productivity across various sectors. Their core product offerings include a suite of software applications designed to optimize operational workflows, data management, and customer engagement processes. These products serve a diverse client base, including small to medium-sized enterprises (SMEs) and large corporations across multiple industries such as technology, finance, and manufacturing. The solutions address specific end-use cases, such as improving data analytics capabilities, streamlining communication channels, and automating routine tasks. Sophont's products are primarily marketed in North America and Europe, targeting customers seeking innovative tools for competitive advantage.Sophont's revenue model relies on subscription-based services and direct sales of its software products. Clients typically enter into annual contracts granting access to the company's software suite, complemented by ongoing support and updates. The transactions are structured for seamless integration into existing business operations, allowing clients to maximize the software's value. Pricing plans are tailored to different tiers based on usage scale and specific features, offering flexibility for both B2B and direct-to-consumer engagements. The flagship products are positioned as premium offerings, catering to high-demand scenarios and reinforcing the company's strategy to deliver high-quality solutions.Sophont Inc. recently raised an undisclosed amount of pre-seed funding as part of a larger USD 9.22 million pre-seed and Seed funding round from unspecified investors. In September 2025, Sophont Inc. raised an undisclosed amount in seed funding led by new investor Kindred Ventures, with participation from other new investors MeiVentures, Delphi Ventures, Upfront Ventures, Brightwing Capital, Aiconic Ventures, and Headwater Ventures. Individual and other unspecified investors also participated in the round. This funding will be utilized to grow its engineering team, expand its AI medical platform, and support clinical research collaborations. The company is focusing on developing new products and enhancing existing ones, although specific release dates have not been disclosed. Additionally, there are plans to expand into new geographic regions, with North America and Europe as primary targets for increased market penetration.

## Funding rounds

- Seed, Sep 11, 2025, $9.2M — Delphi Ventures, Upfront, Kindred Ventures, Headwater Ventures, MeiVentures, Aiconic Ventures

## Investors

- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Seed
- Upfront (https://capitalatlas.ai/funds/upfront) — Seed
- Kindred Ventures (https://capitalatlas.ai/funds/kindred-ventures) — Seed
- Headwater Ventures (https://capitalatlas.ai/funds/headwater-ventures) — Seed
- MeiVentures (https://capitalatlas.ai/funds/meiventures) — Seed
- Aiconic Ventures — Seed